DMRA · Damora Therapeutics, Inc. · Exempt Offerings
$21.96
+0.70 (+3.29%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.36B
Shares
61.74M
Volume · Oct 27
286.1K
Avg daily vol (3M)
520.19K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.